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Amphibians secrete a mixture of biologically active compounds from within glands under the
skin in response to attack by predators. One of the major class of compounds secreted in this
biological arsenal are bioactive polypeptides. These peptides possess many biological
functions including acting as antibiotics, anti cancer agents and inhibiting the formation of








spectrometry of peptides contains significant sequencing information
obtained in the positive ion mode. Information unique to negative ion
of peptides includes fragmentations (i) identifying the presence of a
in the sequence (Ser, Thr, Asp, Asn, Gln, Glu) and (ii) identifying the
amino acids within the peptide sequence (Phe, ser, Thr, Asp, Asn, Gln,
The skin secretion of the Litoria eucnemis contains four novel peptides belonging to two
peptide families 
- 
the caerin 1s and maculatins and is the first Australian frog investigated to
demonstrate this property. Three of the peptides exhibit antibacterial and anticancer
activities. However, the three peptides are some of the least active, among their respective
families.
primary and secondary structural properties are important factors in determining the
biological activity of polypeptides. The solution structures of three peptides Ala4lysl4-
citopin 1.1 (amphiparhic o-helix), Glyl5Glyl9-caerin 1.1 (a less-defined ü-helix) and
frenatin 3.1 (amphipathic cr-helix with a flexible C-terminal end) are presented in a discussion
about this structure/activity relationship.
vil
